Guardant Health, Inc. (GH) vs Waters Corporation (WAT)
Guardant Health, Inc. and Waters Corporation are both Diagnostics & Research companies. Waters Corporation is the larger, with a market value of $42.3B against $23.9B — 1.8× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Waters Corporation trades at 108×. Waters Corporation grew revenue faster over the last twelve months: 52.5% against 42.7%. Waters Corporation has the higher net margin (3.59% vs −38.3%) and the higher return on invested capital (1.05% vs −129.7%). Across the 18 metrics below, Waters Corporation leads on 11 and Guardant Health, Inc. on 7.
Valuation
Profitability
| Metric | GH | WAT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 50.89% | 50.89% |
| Operating margin | (39.75%) | 7.10% | (8.57%) |
| Net margin | (38.33%) | 3.59% | (6.37%) |
| Free cash flow margin | (20.35%) | 7.89% | 0.00% |
| Return on equity | 171.64% | 1.92% | (2.92%) |
| Return on assets | (27.95%) | 1.13% | (6.71%) |
| Return on invested capital | (129.70%) | 1.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack